Cargando…

Immunomodulatory Therapies for the Treatment of Graft-versus-host Disease

Allogeneic hematopoietic stem cell transplantation (allo-HCT) is a potentially curative therapy for patients suffering from hematological malignancies, and its therapeutic success is based on the graft-versus-leukemia (GvL) effect. Severe acute and chronic graft-versus-host disease (GvHD) are life-t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Braun, Lukas M., Zeiser, Robert
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8171375/ https://www.ncbi.nlm.nih.gov/pubmed/34095764 http://dx.doi.org/10.1097/HS9.0000000000000581

Ejemplares similares

Kinase Inhibition as Treatment for Acute and Chronic Graft-Versus-Host Disease
por: Braun, Lukas M., et al.
Publicado: (2021)

Novel Treatment for Graft-versus-Host Disease
por: Inamoto, Yoshihiro, et al.
Publicado: (2021)

Extracorporeal photopheresis in acute and chronic steroid‑refractory graft-versus-host disease: an evolving treatment landscape
por: Greinix, Hildegard T., et al.
Publicado: (2022)

Editorial: Non-coding RNAs and Graft versus Host Disease
por: Reddy, Pavan, et al.
Publicado: (2018)

Novel therapies for graft versus host disease with a focus on cell therapies
por: Zeiser, Robert, et al.
Publicado: (2023)

The Role of Purine Metabolites as DAMPs in Acute Graft-versus-Host Disease
por: Apostolova, Petya, et al.
Publicado: (2016)

The Role of MicroRNAs in Myeloid Cells during Graft-versus-Host Disease
por: Chen, Sophia, et al.
Publicado: (2018)

Editorial on Translational Research in Graft-Versus-Host Disease (GVHD) and Graft-Versus-Tumor (GVT) Effect After Allogeneic Hematopoietic Cell Transplantation
por: Czech, Marie, et al.
Publicado: (2022)

Interfering With Inflammation: Heterogeneous Effects of Interferons in Graft-Versus-Host Disease of the Gastrointestinal Tract and Inflammatory Bowel Disease
por: Haring, Eileen, et al.
Publicado: (2021)

Acute Graft-Versus-Host Disease, Infections, Vascular Events and Drug Toxicities Affecting the Central Nervous System
por: Vinnakota, Janaki Manoja, et al.
Publicado: (2021)

New Approaches for the Treatment of Chronic Graft-Versus-Host Disease: Current Status and Future Directions
por: Saidu, Nathaniel Edward Bennett, et al.
Publicado: (2020)

Bile acids regulate intestinal antigen presentation and reduce graft-versus-host disease without impairing the graft-versus-leukemia effect
por: Haring, Eileen, et al.
Publicado: (2020)

Immunotherapy in Myeloproliferative Diseases
por: Braun, Lukas M., et al.
Publicado: (2020)

Cutaneous Graft-Versus-Host Disease: Diagnosis and Treatment
por: Strong Rodrigues, Karla, et al.
Publicado: (2017)

Advances in the treatment of acute graft-versus-host disease
por: Qian, Liren, et al.
Publicado: (2013)

Application of MultiStem(®) Allogeneic Cells for Immunomodulatory Therapy: Clinical Progress and Pre-Clinical Challenges in Prophylaxis for Graft Versus Host Disease
por: Vaes, Bart, et al.
Publicado: (2012)

Novel regulatory therapies for prevention of Graft-versus-host disease
por: Leventhal, Joseph, et al.
Publicado: (2012)

Acute graft versus host disease
por: Jacobsohn, David A, et al.
Publicado: (2007)

Targeting CD83 for the treatment of graft-versus-host disease
por: WANG, XIONGFEI, et al.
Publicado: (2013)

Regulatory T Cell Therapy of Graft-versus-Host Disease: Advances and Challenges
por: Hefazi, Mehrdad, et al.
Publicado: (2021)

Ruxolitinib for Therapy of Graft-versus-Host Disease
por: Neumann, Thomas, et al.
Publicado: (2019)

Protein dysregulation in graft versus host disease
por: Qian, Liren, et al.
Publicado: (2017)

Targeting Histone Deacetylases to Modulate Graft-Versus-Host Disease and Graft-Versus-Leukemia
por: Kim, Sena, et al.
Publicado: (2020)

Therapeutic targeting of endoplasmic reticulum stress in acute graft-versus-host disease
por: Haring, Eileen, et al.
Publicado: (2021)

Recent advances in graft-versus-host disease
por: Flinn, Aisling M, et al.
Publicado: (2023)

Therapeutics for Graft-versus-Host Disease: From Conventional Therapies to Novel Virotherapeutic Strategies
por: Villa, Nancy Y., et al.
Publicado: (2016)

Editorial: Pathogenesis and Therapy of Graft-versus-Host Disease
por: Betts, Brian C., et al.
Publicado: (2019)

Update on ocular graft-versus-host disease
por: Nair, Sridevi, et al.
Publicado: (2021)

T cell metabolism in graft-versus-host disease
por: Zou, Yujing, et al.
Publicado: (2020)

Cell-based therapy in prophylaxis and treatment of chronic graft-versus-host disease
por: Doglio, Matteo, et al.
Publicado: (2022)

Treatment of chronic graft-versus-host disease: Past, present and future
por: Martin, Paul J., et al.
Publicado: (2011)

Treatment of Graft-versus-Host Disease with Naturally Occurring T Regulatory Cells
por: Trzonkowski, Piotr, et al.
Publicado: (2013)

Fecal Microbiota Transplantation for Treatment of Acute Graft-versus-Host Disease
por: Shouval, Roni, et al.
Publicado: (2019)

Current perspectives on mesenchymal stromal cell therapy for graft versus host disease
por: Kadri, Nadir, et al.
Publicado: (2023)

A diagnostic window for the treatment of acute graft-versus-host disease prior to visible clinical symptoms in a murine model
por: Bäuerlein, Carina A, et al.
Publicado: (2013)

The Role of Fecal Microbiota Transplantation in the Treatment of Acute Graft-versus-Host Disease
por: Biliński, Jarosław, et al.
Publicado: (2022)

Effect of Vitamin D on Graft-versus-Host Disease
por: Rodríguez-Gil, Alfonso, et al.
Publicado: (2022)

Graft-versus-Host Disease Modulation by Innate T Cells
por: Fang, Ying, et al.
Publicado: (2023)

Mesenchymal stem cells: a promising way in therapies of graft-versus-host disease
por: Zhou, Xinyi, et al.
Publicado: (2020)

Shellfish allergy–induced overlap chronic graft-versus-host disease
por: Braun, Hayley Anne, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_a1hv80pdkb66nu3kcsh1t5cpd2